Thus, BC cell-derived Mstn likely binds to its heterodimeric receptor complex ActRIIA or IIB on the surface of progenitor cells and mature OCs, leading to subsequent activation of SMAD2 and ultimately to the expression of several OC-specific target genes. This evidence concerns the gene MSTN and breast cancer.